Dextrose Monohydrate 70% Injection Shortage: Current Availability and Manufacturer Status
The FDA reports a current shortage of Dextrose Monohydrate 70% Injection, though major manufacturers currently list the medication as available.
What’s in Shortage
Dextrose Monohydrate 70% Injection (Brand Name: DEXTROSE) is currently listed in a shortage status. This medication is an injection used across several therapeutic categories, including Endocrinology/Metabolism, Gastroenterology, Pediatrics, and other clinical applications.
- Generic Name: Dextrose Monohydrate 70% Injection
- Dosage Form: Injection
- Current Status: Current
- Initial Posting Date: 10/11/2024
- Last Updated: 02/02/2026
Which Manufacturers Are Affected
While the drug remains on the shortage list, the following manufacturers currently report their presentations as available:
- Baxter Healthcare: Available
- Presentation: Dextrose Monohydrate 70%, Injection, 70 g/100 mL (NDC 0338-0719-06)
- Contact: 888-229-0001
- B. Braun Medical Inc.: Available
- Presentation: Dextrose Monohydrate 70%, Injection, 70 g/100 mL (NDC 0264-7387-50)
- Contact: 800-227-2862
- Otsuka ICU Medical LLC: Available
- Note: This product is distributed by ICU Medical.
- Presentations: DEXTROSE 70% IN PLASTIC CONTAINER, Injection, 70 g/100 mL (NDC 0990-7120-07 and NDC 0990-7918-19)
- Contact: 1-866-829-9025 or [email protected]
Why There’s a Shortage
No specific reason was provided in the source data regarding the cause of this shortage status.
What Patients Should Do
If you or a family member requires Dextrose Monohydrate 70% Injection, please take the following practical steps:
- Consult Your Healthcare Provider: Discuss your treatment plan and any concerns about medication availability with your doctor. They can provide guidance tailored to your specific medical needs.
- Talk to Your Pharmacist: Pharmacists can check current stock levels and may be able to assist in sourcing the medication from different distributors.
- Contact Manufacturers: If you are having difficulty locating the medication, you may use the contact numbers provided above to ask about regional availability.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Patients should always consult with their healthcare provider or professional medical team regarding medication changes or treatment options.
Source
Information attributed to the FDA Drug Shortage Database.
Source: FDA Official Notice
Related Articles
Streptozocin (Zanosar) Oncology Medication Facing Ongoing Supply Shortage
FDA · February 11, 2026
Cromolyn Sodium Concentrate (Gastrocrom) Shortage: Current FDA Status and Availability
FDA · February 11, 2026
Quinapril/Hydrochlorothiazide Tablet Shortage: Current FDA Status and Availability Updates
FDA · February 11, 2026